All News
Opinion: Gene therapy trials should emphasize transparency, not secrecy
After two recent deaths in gene therapy clinical trials, the industry needs to be more open to sharing information to protect participants.
Read MoreLupin Digital Health partners with Medicover Hospitals to provide post-operative care for cardiac patients
This partnership aims to reshape cardiac care in India, offering at-home rehabilitation, powered by digital therapeutics The post Lupin Digital Health partners with Medicover Hospitals to provide
Read MoreAI innovation is crucial within healthcare: Anupriya Patel
The medical device sector in India is recognized as a sunrise sector because of its immense growth potential driven by the country's increasing healthcare needs, technological innovations, government
Read MoreMaxivision to invest Rs 200 crore for Gujarat expansion, targets 25 hospitals
A super specialty center is planned in Ahmedabad as a Greenfield project.
Read MoreBest of 2024: ‘It comes for your very soul’: how Alzheimer’s undid my dazzling, creative wife in her 40s – podcast
Every Monday and Friday for the rest of December we will publish some of our favourite audio long reads of 2024, in case you missed them, with an introduction from the editorial team to explain why we
Read MoreLong COVID Symptoms Improve With Outpatient Intervention
(MedPage Today) -- Self-reported physical function was better for long COVID patients after a brief outpatient program based on cognitive and behavioral therapy, a pragmatic trial in Norway showed.
Read MoreKFF Health News' 'What the Health?': End-of-Year Chaos on Capitol Hill
Democrats and Republicans in the House and Senate successfully negotiated an enormous end-of-Congress health package, including bipartisan efforts to address prescription drug prices — only to see i
Read MoreSTAT+: Ionis wins FDA approval for a rare disease therapy that lowers triglycerides
Ionis won FDA approval for a drug for patients with a deadly genetic disease that impedes the body’s ability to break down fats
Read MoreSTAT+: Gilead plans to halt free access to an HIV drug, worrying patient advocates
Gilead Sciences will no longer provide four HIV medicines for free as part of a patient assistance program starting at the end of January.
Read MoreSTAT+: FDA OKs novel device for non-invasive treatment of spinal cord injuries
The FDA Thursday approved the ARC-EX System designed to restore mobility after spinal cord injury by delivering programmed stimulation via electrodes placed on back of neck.
Read More